The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges

Overview

Journal Life (Basel)

Specialty Biology

Date 2022 Aug 26

PMID 36013323

Authors

Salvatore Costa

Maria Antonietta Ragusa

Gabriele Lo Buglio

Simone Dario Scilabra

Aldo Nicosia

Affiliations

Soon will be listed here.

Abstract

Tissue inhibitors of metalloproteases (TIMPs) belong to a fascinating protein family expressed in all Metazoa. They act as regulators of the turnover of the extracellular matrix, and they are consistently involved in essential processes. Herein, we recapitulate the main activities of mammalian TIMPs (TIMP1-4) in the control of extracellular-matrix degradation and pathologies associated with aberrant proteostasis. We delineate the activity of TIMPs in the control of extracellular matrix (ECM) homeostasis and discuss the diversity of TIMPs across metazoans taking into account the emergence of the components of the ECM during evolution. Thus, the TIMP repertoire herein analysed includes the homologues from cnidarians, which are coeval with the origins of ECM components; protostomes (molluscs, arthropods and nematodes); and deuterostomes (echinoderms and vertebrates). Several questions, including the maintenance of the structure despite low sequence similarity and the strategies for TIMP engineering, shed light on the possibility to use recombinant TIMPs integrating unique features and binding selectivity for therapeutic applications in the treatment of inflammatory pathologies.

Citing Articles

The Multifaced Role of Collagen in Cancer Development and Progression.

Lo Buglio G, Lo Cicero A, Campora S, Ghersi G Int J Mol Sci. 2025; 25(24.

PMID: 39769286 PMC: 11678882. DOI: 10.3390/ijms252413523.

Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.

Zeng X, Lafferty T, Sehrawat A, Chen Y, Ferreira P, Bellaver B Mol Neurodegener. 2024; 19(1):68.

PMID: 39385222 PMC: 11465638. DOI: 10.1186/s13024-024-00753-5.

ADAMTS Proteases: Their Multifaceted Role in the Regulation of Cancer Metastasis.

Bacchetti R, Yuan S, Rainero E Dis Res. 2024; 4(1):40-52.

PMID: 38948119 PMC: 7616120. DOI: 10.54457/DR.202401004.

Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.

Zeng X, Lafferty T, Sehrawat A, Chen Y, Ferreira P, Bellaver B medRxiv. 2024; .

PMID: 38947065 PMC: 11213097. DOI: 10.1101/2024.06.15.24308975.

Redefining metalloproteases specificity through network proteolysis.

Kollet O, Das A, Karamanos N, Auf dem Keller U, Sagi I Trends Mol Med. 2023; 30(2):147-163.

PMID: 38036391 PMC: 11004056. DOI: 10.1016/j.molmed.2023.11.001.

References

Pohar N, Godenschwege T, Buchner E . Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. Genomics. 1999; 57(2):293-6. DOI: 10.1006/geno.1999.5776. View

Hamze A, Wei S, Bahudhanapati H, Kota S, Acharya K, Brew K . Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. Protein Sci. 2007; 16(9):1905-13. PMC: 2206984. DOI: 10.1110/ps.072978507. View

Yan L, Leontovich A, Fei K, Sarras Jr M . Hydra metalloproteinase 1: a secreted astacin metalloproteinase whose apical axis expression is differentially regulated during head regeneration. Dev Biol. 2000; 219(1):115-28. DOI: 10.1006/dbio.1999.9568. View

Baker A, George S, Zaltsman A, Murphy G, Newby A . Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer. 1999; 79(9-10):1347-55. PMC: 2362728. DOI: 10.1038/sj.bjc.6690217. View

Bosch T . Why polyps regenerate and we don't: towards a cellular and molecular framework for Hydra regeneration. Dev Biol. 2007; 303(2):421-33. DOI: 10.1016/j.ydbio.2006.12.012. View

Bloom J, Drummond D, Arnold F, Wilke C . Structural determinants of the rate of protein evolution in yeast. Mol Biol Evol. 2006; 23(9):1751-61. DOI: 10.1093/molbev/msl040. View

Doherty C, Visse R, Dinakarpandian D, Strickland D, Nagase H, Troeberg L . Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity. J Biol Chem. 2016; 291(42):22160-22172. PMC: 5063997. DOI: 10.1074/jbc.M116.733261. View

Ball E, Hayward D, Saint R, Miller D . A simple plan--cnidarians and the origins of developmental mechanisms. Nat Rev Genet. 2004; 5(8):567-77. DOI: 10.1038/nrg1402. View

Lieu S, Hansen E, Dedini R, Behonick D, Werb Z, Miclau T . Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2. Dis Model Mech. 2010; 4(2):203-11. PMC: 3046093. DOI: 10.1242/dmm.006304. View

10.

Lizarraga F, Espinosa M, Ceballos-Cancino G, Vazquez-Santillan K, Bahena-Ocampo I, Schwarz-Cruz Y Celis A . Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells. Mol Carcinog. 2015; 55(12):1952-1961. DOI: 10.1002/mc.22442. View

11.

Arkadash V, Yosef G, Shirian J, Cohen I, Horev Y, Grossman M . Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution. J Biol Chem. 2017; 292(8):3481-3495. PMC: 5336179. DOI: 10.1074/jbc.M116.756718. View

12.

Murphy G, Nagase H . Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?. Nat Clin Pract Rheumatol. 2008; 4(3):128-35. DOI: 10.1038/ncprheum0727. View

13.

Escalona R, Bilandzic M, Western P, Kadife E, Kannourakis G, Findlay J . TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. BMC Cancer. 2020; 20(1):960. PMC: 7542139. DOI: 10.1186/s12885-020-07274-6. View

14.

Masson D, Rioux-Leclercq N, Fergelot P, Jouan F, Mottier S, Theoleyre S . Loss of expression of TIMP3 in clear cell renal cell carcinoma. Eur J Cancer. 2010; 46(8):1430-7. DOI: 10.1016/j.ejca.2010.01.009. View

15.

Xu X, Shen Y, Yang X, Li J . Cloning and characterization of TIMP-2b gene in grass carp. Comp Biochem Physiol B Biochem Mol Biol. 2011; 159(2):115-21. DOI: 10.1016/j.cbpb.2011.02.008. View

16.

Spano D, Scilabra S . Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding. Membranes (Basel). 2022; 12(2). PMC: 8878240. DOI: 10.3390/membranes12020211. View

17.

Barski D, Wolter M, Reifenberger G, Riemenschneider M . Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol. 2009; 20(3):623-31. PMC: 8094659. DOI: 10.1111/j.1750-3639.2009.00340.x. View

18.

Ratajczak-Wielgomas K, Gosk J, Rabczynski J, Augoff K, Podhorska-Okolow M, Gamian A . Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren's contracture. Connect Tissue Res. 2012; 53(6):469-77. DOI: 10.3109/03008207.2012.686542. View

19.

Hekmat O, Munk S, Fogh L, Yadav R, Francavilla C, Horn H . TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells. J Proteome Res. 2013; 12(9):4136-51. DOI: 10.1021/pr400457u. View

20.

Roten L, Nemoto S, Simsic J, Coker M, Rao V, Baicu S . Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice. J Mol Cell Cardiol. 2000; 32(1):109-20. DOI: 10.1006/jmcc.1999.1052. View